New Horizons in Diagnostic Imaging and Radioactive Tracers: Managed Care Strategies for Improved Clinical and Economic Outcomes
 
 A continuing medical education and nursing continuing professional
development activity provided by NAMCP and AAMCN.

This activity is an archive from the live webinar on August 14, 2024. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from September 1, 2024 to September 1, 2025
 

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
GE Healthcare

Description:
As our population ages and the burden of caring for older adults increases, the search for improved diagnosis and novel radiopharmaceuticals for cancer, dementia, movement disorders, epilepsy, heart disease has become a top priority facing all healthcare professionals. Radiopharmaceuticals are a growing group of radioactive drugs used for diagnostic and therapeutic interventions. Advances in diagnostic imaging have the potential to personalize care. These disease-specific or target-specific imaging agents help clinicians determine the most appropriate course of treatment and management, namely precision medicine. This live webinar series will take a close look at these new options and best practices in diagnostic imaging, radiopharmaceuticals, and radioactive tracers for managed care professionals.

Upon completion of this activity, participants will be able to:

  • Examine the components and principles of the various imaging modalities used in radiology and nuclear medicine

  • Explore the evolving diagnostic applications of radioactive tracers in neurology

  • Evaluate the evolving role of molecular imaging in the diagnosis of early Alzheimer's disease to facilitate treatment with novel options
     

Faculty:
Lawrence N. Tanenbaum, MD, FACR
VP & Chief Technology Officer, Medical Director Eastern Region
RadNet
tanenbaum@radnet.com

Disclosure Information:
As accredited providers, NAMCP and AAMCN must ensure balance, independence, objectivity, and scientific rigor in all of their activities. All faculty participating in this activity are required to disclose to NAMCP/AAMCN any financial relationships with ineligible companies. NAMCP/AAMCN in turn discloses all relevant financial conflicts to the learners. NAMCP/AAMCN disclosure policy adheres to The Standards for Integrity and Independence in Accredited Continuing Education. All relevant conflicts of interest have been mitigated prior to the commencement of the activity. See below for conflicts of interest.

Disclosures (Relevant Financial Relationships with Ineligible Companies in the Last 24 Months):
Dr. Tanenbaum has served as a consultant for icometrix. All relevant conflicts of interest have been mitigated.

Planning Committee Disclosures (Relevant Financial Relationships with Ineligible Companies in the Last 24 Months):
Bill Williams, MD has no relevant financial relationship with an ineligible company to disclose.
Jeremy Williams has no relevant financial relationship with an ineligible company to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationship with an ineligible company to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

NAMCP and/or this website do not provide medical advice, diagnosis, or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health-related concern, consult with your physician or healthcare professional.

This activity is supported by an educational grant from
GE Healthcare


NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue